NatWest Group’s Integra LifeSciences IART Stock Holding History

NatWest Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-137,685	Closed	-$2.59M	–	555
2014 Q1	$2.59M	Hold	137,685	–	–	0.11%	153
2013 Q4	$2.69M	Hold	137,685	–	–	0.07%	234
2013 Q3	$2.27M	Sell	137,685 -1,179	-0.8%	-$18.9K	0.07%	242
2013 Q2	$2.08M	Buy	+138,864	New	+$2.03M	0.03%	313

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NatWest Group's IART Position: Q2 2014 in Review

NatWest Group sold out of Integra LifeSciences (IART) in Q2 2014, closing a stake of 137,685 shares — an estimated $2.59M sold.

NatWest Group first reported a position in IART in Q2 2013 and held it in 4 quarters. The position peaked at $2.69M in Q4 2013. 147 funds tracked by Wall St. Rank hold IART as of Q2 2014.

NatWest Group reported no remaining Integra LifeSciences position as of Q2 2014 after selling out during the quarter.
NatWest Group sold 137,685 Integra LifeSciences shares in Q2 2014, an estimated $2.59M.
NatWest Group first reported a position in Integra LifeSciences in Q2 2013 and held it in 4 quarters.
NatWest Group's Integra LifeSciences position peaked at $2.69M in Q4 2013.
147 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2014.

Based on NatWest Group's 13F filing for Q2 2014, filed 13 Aug 2014.